biotin has been researched along with naloxone in 4 studies
| Studies (biotin) | Trials (biotin) | Recent Studies (post-2010) (biotin) | Studies (naloxone) | Trials (naloxone) | Recent Studies (post-2010) (naloxone) |
|---|---|---|---|---|---|
| 14,847 | 95 | 3,882 | 20,134 | 1,257 | 3,321 |
| Protein | Taxonomy | biotin (IC50) | naloxone (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 2 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.043 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0219 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0019 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0397 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1896 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.05 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0795 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0154 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0089 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.0055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Calvo, F; Carvalho, AD; Castellan-Baldan, L; Coimbra, NC; da Silva, LA; de Oliveira, R; Elias-Filho, DH; Felippotti, TT; Motta, V; Osaki, MY; Paschoalin-Maurin, T; Ubiali, WA | 1 |
| Ford, CP; Mark, GP; Williams, JT | 1 |
| Colago, EE; Gallegos, RA; Henriksen, SJ; Koob, GF; Lee, RS; Steffensen, SC; Stobbs, SH | 1 |
4 other study(ies) available for biotin and naloxone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of mu(1)- and kappa-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus.
Topics: Animals; Biotin; Dextrans; Dose-Response Relationship, Drug; Electric Stimulation; Escape Reaction; Fear; Inferior Colliculi; Male; Naloxone; Naltrexone; Narcotic Antagonists; Neural Pathways; Opioid Peptides; Periaqueductal Gray; Presynaptic Terminals; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2003 |
Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location.
Topics: Amygdala; Analgesics; Animals; Bicuculline; Biotin; Cell Count; Dopamine; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Female; GABA Antagonists; Immunohistochemistry; In Vitro Techniques; Limbic System; Male; Membrane Potentials; Mice; Mice, Inbred DBA; Microinjections; Molecular Sequence Data; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neural Pathways; Neurons; Nucleus Accumbens; Patch-Clamp Techniques; Reaction Time; Serotonin; Serotonin Receptor Agonists; Synaptic Transmission; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2006 |
Contingent and non-contingent effects of heroin on mu-opioid receptor-containing ventral tegmental area GABA neurons.
Topics: Action Potentials; Animals; Behavior, Animal; Biotin; Dopamine; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; gamma-Aminobutyric Acid; Heroin; Immunohistochemistry; Male; Microscopy, Immunoelectron; Naloxone; Narcotic Antagonists; Narcotics; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Self Administration; Ventral Tegmental Area; Wakefulness | 2006 |